The emerging trend in diabetes care is undoubtedly centered around GLP-1 therapies, and BrightMeds is spearheading this shift. These innovative drugs, initially developed for treating type 2 diabetes, are now widely prescribed – or researched – for their remarkable ability to promote weight loss and improve general health. BrightMeds' version o